Accenture Recognized as the Leading Global Service Provider to the Healthcare Industry

NEW YORK; Jan. 18, 2021 – Accenture (NYSE: ACN) has been named the number one service provider for the healthcare sector in a recent report from industry analyst firm HFS Research.
January 18, 2021

Medable Named Life Sciences Innovation Champion in the Accenture HealthTech Innovation Challenge

NEW YORK; Dec. 16, 2020 – Medable has been named the Accenture HealthTech Innovation Challenge – Life Sciences Innovation Champion for providing patients with an integrated digital and physical experience during clinical trials, allowing them to access clinical care sites and clinical trial teams from their mobile phones. Medable was one of five finalists invited to pitch their innovative solutions to a panel of life sciences leaders during a virtual event held earlier this week.
December 16, 2020

Accenture Recognized as a Leading Provider of Financial Improvement Services to Healthcare Industry

NEW YORK; Dec. 9, 2020 – Accenture (NYSE: ACN) has been named a leading provider of financial improvement consulting services to healthcare organizations in a recent report from industry analyst firm KLAS Research, receiving a ranking of 94.7 out of 100.
December 09, 2020

Accenture, Orexo Team to Offer Digital Therapeutics Through INTIENT™ Platform

NEW YORK and MORRISTOWN, N.J.; Nov. 16, 2020 ‒ Accenture (NYSE: ACN) has helped the U.S. subsidiary of Swedish pharmaceutical company Orexo launch its first digital therapeutic, vorvida®, for patients in the United States dealing with problematic alcohol use. vorvida® is a web-based digital platform that uses the INTIENT™ Patient solution suite, which is powered by Google Cloud, to enable secure patient interactions and connectivity to an ecosystem of third-party health care services.
November 16, 2020

Accenture and Tokyo Women’s Medical University to Conduct Joint Research on Potential Benefits of Artificial Intelligence for Kidney Transplant Treatment

TOKYO; Nov. 5, 2020 – Accenture (NYSE:ACN) and Tokyo Women’s Medical University (TWMU) have agreed to conduct joint research using artificial intelligence (AI) to verify and analyze kidney transplant test results, recognize early-stage kidney transplant rejection tendencies and to foresee side effects in efforts to identify more effective post-operation treatments for patients.
November 04, 2020

Accenture and Springboard Enterprises Celebrate Women Transforming Industries

NEW YORK; Oct. 22, 2020 – Accenture (NYSE: ACN) and Springboard Enterprises are celebrating “Women Transforming Industries” and the organization’s 20th anniversary by honoring four women CEOs in the retail and health industries for their technological innovation.
October 22, 2020

Takeda Accelerates Digital Transformation with Accenture and AWS

OSAKA, Japan; NEW YORK; and SEATTLE; October 13, 2020 – Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) (“Takeda”), Accenture (NYSE: ACN) and Amazon Web Services (AWS) have entered into a five-year strategic agreement to accelerate Takeda’s digital transformation.
October 13, 2020

Pharma Companies Have Improved How They Engage with Healthcare Providers During COVID-19, Finds New Research from Accenture

NEW YORK; Aug. 10, 2020 – As a result of COVID-19, pharmaceutical companies are changing how they engage with healthcare providers (HCPs), which is helping HCPs better serve patients, according to findings of an Accenture (NYSE: ACN) survey of 720 general practitioners, oncologists, cardiologists and immunologists globally.
 
August 10, 2020

Accenture Named a Leader in Everest Group’s Medical Devices Digital Services PEAK Matrix® Assessment 2020

NEW YORK; July 13, 2020 – Accenture (NYSE: ACN) is positioned as a Leader in medical devices digital services in a new report from independent research firm Everest Group.
 
July 13, 2020

Patients Want to Continue to Use Virtual Care Even After the Pandemic Ends, Accenture Survey Finds

NEW YORK; July 9, 2020 – Patients have embraced virtual care and communications at very high rates as a result of COVID-19 and nine out of 10 reported the quality of care was as good or better than before, according to findings of an Accenture (NYSE: ACN) survey of 2,700 oncology, cardiology, or immunology patients globally.
July 09, 2020